Evolution of Oncogenic Signatures Within Glioblastoma Along a Spatiotemporal Axis
ISEF · 2022 Biomedical and Health Sciences Fourth Award
Overview
Glioblastoma is a malignant tumor of the central nervous system distinguished by its intra-tumoral heterogeneity and inevitable recurrence. A longitudinal axis of genomic evolution has been identified between two spatially defined identities, tumor edge and core. This study sought to characterize this transition as a potential therapeutic target. Publicly available RNA-seq data was used to identify significant differentially expressed genes. These DEGs (n=105) were then further analyzed at both the individual gene level and at the whole genome level. Transcription factor enrichment analysis revealed the oncogenic transcription factor FOXM1 as a statistically significant mediator of downregulated target genes. Protein-protein interaction network analysis of DEGs revealed the oncogenic protein kinase MELK as over-represented within the core. The protein complex of MELK and FOXM1 has been characterized to transcriptionally regulate the enzymatic catalytic subunit EZH2, which in turn promotes radio-resistance. Clinically, the co-expression of EZH2 and MELK is induced in recurrent tumors. Small molecules and drugs that reverse this spatiotemporal gene expression signature were identified. Collectively, this systematic comparison of tumor core/edge and the identification of DEGs as critical instigators of therapeutic resistance provides a coherent portrait of the prognostically-significant shift in molecular phenotypes associated with the spatiotemporal axis. This intra-patient heterogeneity highlights the importance of eradication of the tumor edge to prevent the lethal GBM recurrence. Additionally, these data link this lethal axis to the edge-to-core transition and indicate MELK-FOXM1-driven EZH2 signaling as a therapeutic target in postsurgical GBM tumors.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2021
Intratumoral Heterogeneity in Gene Expression within Single Glioblastoma Tumors
ISEF · 2021
Comparative Analysis of Genetic Mutations and Overall Survival in Patients with Glioblastoma Multiforme: A Retrospective Cohort Study
ISEF · 2024
The Effect of Somatic Mutations in Glioblastoma Multiforme on Patient Survival
ISEF · 2021
Differential Expression Analysis and Transcriptomic Characterization of Glioma Progression
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair